CVS HEALTH CORPORATION (CVS) Total liabilities 2016–2025
CVS HEALTH CORPORATION (CVS) total liabilities at each fiscal year-end, per SEC filings.
$178.2BFY2025 · since FY2016: $57.6B → $178.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $178.2B | +0.4% |
| FY2024 | $177.5B | +2.5% |
| FY2023 | $173.1B | +10.6% |
| FY2022 | $156.5B | -1.1% |
| FY2021 | $158.2B | -1.7% |
| FY2020 | $161.0B | +1.7% |
| FY2019 | $158.3B | +14.8% |
| FY2018 | $137.9B | +140.1% |
| FY2017 | $57.4B | -0.3% |
| FY2016 | $57.6B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice